Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;34(2):e13045.
doi: 10.1111/jne.13045. Epub 2021 Oct 13.

Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

Delia Belelli  1 , Grant D Phillips  1 , John R Atack  2 , Jeremy J Lambert  1
Affiliations
Review

Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

Delia Belelli et al. J Neuroendocrinol. 2022 Feb.

Abstract

Studies in the 1980s revealed endogenous metabolites of progesterone and deoxycorticosterone to be potent, efficacious, positive allosteric modulators (PAMs) of the GABAA receptor (GABAA R). The discovery that such steroids are locally synthesised in the central nervous system (CNS) promoted the thesis that neural inhibition in the CNS may be "fine-tuned" by these neurosteroids to influence behaviour. In preclinical studies, these neurosteroids exhibited anxiolytic, anticonvulsant, analgesic and sedative properties and, at relatively high doses, induced a state of general anaesthesia, a profile consistent with their interaction with GABAA Rs. However, realising the therapeutic potential of either endogenous neurosteroids or synthetic "neuroactive" steroids has proven challenging. Recent approval by the Food and Drug Administration of the use of allopregnanolone (brexanolone) to treat postpartum depression has rekindled enthusiasm for exploring their potential as new medicines. Although neurosteroids are selective for GABAA Rs, they exhibit little or no selectivity across the many GABAA R subtypes. Nevertheless, a relatively minor population of receptors incorporating the δ-subunit (δ-GABAA Rs) appears to be an important contributor to their behavioural effects. Here, we consider how neurosteroids acting upon GABAA Rs influence neuronal signalling, as well as how such effects may acutely and persistently influence behaviour, and explore the case for developing selective PAMs of δ-GABAA R subtypes for the treatment of psychiatric disorders.

Keywords: GABAA receptor; allopregnanolone; major depressive disorder; neurosteroid; postpartum depression.

PubMed Disclaimer

References

REFERENCES

    1. Selye H. Anesthetic effect of steroid hormones. Proc Soc Exp Biol Med. 1941;46:116-121.
    1. Meltzer-Brody S, Colquhoun H, Riesenberg R, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392:1058-1070.
    1. Majewska MD, Harrison NL, Schwartz RD, et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232:1004-1007.
    1. Barker JL, Harrison NL, Lange GD, et al. Potentiation of gamma-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J Physiol. 1987;386:485-501.
    1. Callachan H, Cottrell GA, Hather NY, et al. Modulation of the GABAA receptor by progesterone metabolites. Proc R Soc London Ser B, Biol Sci. 1987;231:359-369.

LinkOut - more resources